NCT02758236 - Tuberculosis Research of INA-RESPOND On Drug Resistance | Biotech Hunter

Enrollment

490

Participants

Timeline

Start Date

February 13, 2017

Primary Completion Date

November 30, 2018

Study Completion Date

April 26, 2021

Conditions

Lung TuberculosisMDR TB

Interventions

OTHER

No Intervention

Trial Locations (7)

Site 590: Persahabatan Hospital, Jakarta

Site 600 : Adam Malik Hospital, Medan

Site 560: University of Diponegoro/ Dr. Kariadi Hospital, Semarang

Site 580: University of Gadjah Mada/ Dr. Sardjito Hospital, Yogyakarta

Site 570: University of Airlangga/ Dr. Soetomo Hospital, Surabaya

Site 520: University of Udayana/Sanglah Hospital, Denpasar

Site 550: University of Hassanudin/ Dr. Wahidin Sudirohusodo Hospital, Makassar

All Listed Sponsors

collaborator

National Institute of Health Research and Development, Ministry of Health Republic of Indonesia

OTHER

collaborator

National Institute of Allergy and Infectious Diseases (NIAID)

NIH

lead

Ina-Respond

OTHER